|Slideshows|May 18, 2017

7 Medical Illnesses That May Present as Anxiety

Author(s)Yu Dong, MD, PhD, Fatima Noorani, MD, Rushi Vyas, MD

Beyond psychosocial implications of anxiety disorders, an array of physiological effects may ensue.

To view a PDF, of this slideshow, click here.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Addressing Sexual Wellness: A Psychiatric Perspective

ByGrace L. Johnson, MD,Alex Rains, MD,Renee Sorrentino, MD

June 11th 2026

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research

ByMark Gerstein, PhD

June 5th 2026

Which Patients Are Less Likely to Believe They Have a Comorbid Mental Health Disorder?

ByMark Zimmerman, MD

May 27th 2026

The Significant Presence of Comorbidities in Bipolar Depression: Insights From Mark Zimmerman, MD

ByMark Zimmerman, MD

May 27th 2026

SYT-510 for Generalized Anxiety Disorder: Phase 2 Trial Dosing Initiated

ByLeah Kuntz

May 20th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

7 Medical Illnesses That May Present as Anxiety

Related Content

Addressing Sexual Wellness: A Psychiatric Perspective

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research

Which Patients Are Less Likely to Believe They Have a Comorbid Mental Health Disorder?

The Significant Presence of Comorbidities in Bipolar Depression: Insights From Mark Zimmerman, MD

SYT-510 for Generalized Anxiety Disorder: Phase 2 Trial Dosing Initiated

Latest CME

Southern California Psychiatry Conference

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Trending on Psychiatric Times

Sex Differences, Sleep Problems, and Psychological Well-Being in Older Adults

Evidence-Based Nonpharmacological Interventions in Schizophrenia: Focus on Cognitive Impairment

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

GABA Deficits and Sleep Disruption in Early Alzheimer Disease